Pancreatic Cancer Research

ResearcherWayne State UniversityNo recent work listed

Subhash Padhyé

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-9401-2007; OpenAlex author ID A5103248527. Sources: OpenAlex.

Their work

Papers
14 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
30
Papers, trials and grants by year

2011: 2 papers · 2012: 3 papers · 2013: 1 paper · 2014: none · 2015: 4 papers · 2016: 1 paper · 2017: none · 2018: 1 paper · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper

Papers 14

  1. Anticancer Activity of Novel Difluorinated Curcumin Analog and Its Inclusion Complex with 2-Hydroxypropyl-β-Cyclodextrin against Pancreatic Cancer. Co-author DOI 10.3390/ijms24076336↗
  2. Diphenylbutylpiperidine Antipsychotic Drugs Inhibit Prolactin Receptor Signaling to Reduce Growth of Pancreatic Ductal Adenocarcinoma in Mice. Co-author DOI 10.1053/j.gastro.2019.11.279↗
  3. Retraction notice to "Increased Ras GTPase activity is regulated by miRNAs that can be attenuated by CDF treatment in pancreatic cancer cells" [Cancer Lett. 31… Co-author DOI 10.1016/j.canlet.2017.11.030↗
  4. Quinomycin A targets Notch signaling pathway in pancreatic cancer stem cells. Co-author DOI 10.18632/oncotarget.6560↗
  5. Parenterally administrable nano-micelles of 3,4-difluorobenzylidene curcumin for treating pancreatic cancer. Co-author DOI 10.1016/j.colsurfb.2015.05.007↗
  6. Hyaluronic acid-conjugated polyamidoamine dendrimers for targeted delivery of 3,4-difluorobenzylidene curcumin to CD44 overexpressing pancreatic cancer cells. Co-author DOI 10.1016/j.colsurfb.2015.09.043↗
  7. Hyaluronic Acid Engineered Nanomicelles Loaded with 3,4-Difluorobenzylidene Curcumin for Targeted Killing of CD44+ Stem-Like Pancreatic Cancer Cells. Co-author DOI 10.1021/acs.biomac.5b00941↗
  8. Crocetinic acid inhibits hedgehog signaling to inhibit pancreatic cancer stem cells. Co-author DOI 10.18632/oncotarget.4871↗
  9. Synthesis, characterization and anti-tumor activity of novel thymoquinone analogs against pancreatic cancer. Last author DOI 10.1016/j.bmcl.2013.03.003↗
  10. Inclusion complex of novel curcumin analogue CDF and β-cyclodextrin (1:2) and its enhanced in vivo anticancer activity against pancreatic cancer. Co-author DOI 10.1007/s11095-012-0700-1↗
  11. RETRACTED: Increased Ras GTPase activity is regulated by miRNAs that can be attenuated by CDF treatment in pancreatic cancer cells. Co-author DOI 10.1016/j.canlet.2012.01.013↗
  12. Hypoxia-induced aggressiveness of pancreatic cancer cells is due to increased expression of VEGF, IL-6 and miR-21, which can be attenuated by CDF treatment. Co-author DOI 10.1371/journal.pone.0050165↗
  13. Anti-tumor activity of a novel compound-CDF is mediated by regulating miR-21, miR-200, and PTEN in pancreatic cancer. Co-author DOI 10.1371/journal.pone.0017850↗
  14. Network modeling of CDF treated pancreatic cancer cells reveals a novel c-myc-p73 dependent apoptotic mechanism. Co-author PMID 21904657↗

Closest collaborators

The 25 strongest of 30 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Fazlul H. Sarkar · 10 shared papers, 2011–2018 · strength 0.46
  2. Sanjeev Banerjee · 8 shared papers, 2011–2015 · strength 0.33
  3. Shrikant Anant · 4 shared papers, 2015–2023 · strength 0.33
  4. Prasad R. Dandawate · 4 shared papers, 2012–2023 · strength 0.32
  5. Anup Kasi · 2 shared papers, 2020–2023 · strength 0.24
  6. Amro Aboukameel · 5 shared papers, 2011–2018 · strength 0.22
  7. Shadan S. Ali · 5 shared papers, 2011–2018 · strength 0.21
  8. Bin Bao · 5 shared papers, 2011–2018 · strength 0.21
  9. Prashant Kesharwani · 3 shared papers, 2015 · strength 0.19
  10. Arun K. Iyer · 3 shared papers, 2015 · strength 0.19
  11. Philip A. Philip · 4 shared papers, 2011–2018 · strength 0.18
  12. Dharmalingam Subramaniam · 3 shared papers, 2015–2020 · strength 0.17
  13. Animesh Dhar · 3 shared papers, 2015–2020 · strength 0.17
  14. Sangita Bhattacharyya · 1 shared paper, 2023 · strength 0.16
  15. Obdulia Covarrubias‐Zambrano · 1 shared paper, 2023 · strength 0.16
  16. Stefan H. Bossmann · 1 shared paper, 2023 · strength 0.16
  17. Michael Nathan VanSaun · 1 shared paper, 2023 · strength 0.16
  18. Weijing Sun · 1 shared paper, 2020 · strength 0.08
  19. Domenico Coppola · 1 shared paper, 2020 · strength 0.08
  20. Chandrayee Ghosh · 1 shared paper, 2020 · strength 0.08
  21. Mokenge Peter Malafa · 1 shared paper, 2020 · strength 0.08
  22. Asfar Sohail Azmi · 2 shared papers, 2011–2012 · strength 0.06
  23. Sivapriya Ponnurangam · 1 shared paper, 2016 · strength 0.05
  24. Danny R. Welch · 1 shared paper, 2015 · strength 0.04
  25. Sitaram Harihar · 1 shared paper, 2015 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.